Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K221934
    Manufacturer
    Date Cleared
    2023-03-09

    (251 days)

    Product Code
    Regulation Number
    870.1250
    Reference & Predicate Devices
    Predicate For
    Why did this record match?
    Reference Devices :

    K173200

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The CEREGLIDE™ 71 Intermediate Catheter, with the Cerenovus Aspiration Tubing Set and a compatible aspiration pump, is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral -M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.

    The Cerenovus Aspiration Tubing Set is intended to connect the Cerenovus Large Bore Catheter of the Nouvag Vacuson 60 Aspiration Pump (or equivalent vacuum pump) and to allow the user to control the fluid flow. The Cerenovus Aspiration Tubing Set is also intended to connect the CEREGLIDE™ 71 Intermediate Catheter to the canister of a compatible aspiration pump and to allow the user to control the fluid flow.

    Device Description

    The CEREGLIDE™ 71 Intermediate Catheter is a variable stiffness, single lumen catheter designed to be introduced over a steerable guide wire or microcatheter into the euro vasculature. The catheter shaft is composed of a stainless steel variable pitch braid with a PTFE inner liner to facilitate movement of guide wires and other devices. The exterior of the catheter shaft is covered with polymer materials, which encapsulate the stainless steel braid construction. The catheter has a stiff proximal shaft which transitions into the flexible distal shaft to facilitate the advancement of the catheter in the anatomy. The distal end of the catheter has a radiopaque marker band to facilitate fluoroscopic visualization and has a hydrophilic coating to provide lubricity to reduce friction during navigation in the vasculature. The proximal end of the catheter has a luer fitting located on the end of the catheter hub which can be used to attach accessories for flushing and aspiration. An ID band is placed at the distal end of the hub over a strain relief.

    The catheter is packaged with a Tuohy Borst rotating hemostasis valve (RHV) with a side port and two slit introducers as accessories. The RHV with side port is used for flushing, insertion of catheters, and connection to an external aspiration system. The slit introducers are designed to introduce the catheter into the base catheter and protect the distal tip of the catheter during insertion into the RHV of the base catheter. The CEREGLIDE™ 71 Intermediate Catheter can be connected to a compatible aspiration pump using the Cerenovus Aspiration Tubing Set.

    AI/ML Overview

    The provided text describes the regulatory clearance of a medical device (CEREGLIDE™ 71 Intermediate Catheter and Cerenovus Aspiration Tubing Set) and outlines the non-clinical performance data used to demonstrate its substantial equivalence to a predicate device. It does not contain information about an AI/ML-driven device or study parameters related to AI/ML performance evaluation. Therefore, I cannot extract the requested information based on the input.

    However, I can provide a summary of the non-clinical performance data presented in the document, which are described as meeting acceptance criteria, albeit not for an AI/ML device.

    Table of Acceptance Criteria and Reported Device Performance (Non-AI/ML)

    TestAcceptance Criteria SummaryReported Device Performance
    Visual InspectionCatheter meets visual requirements described in ISO 10555-1 Section 4.4.PASS: Samples met the established acceptance criteria
    Catheter IDCatheter internal diameters meet requirements.PASS: Samples met the established acceptance criteria
    Catheter ODCatheter outer diameters meet requirements.PASS: Samples met the established acceptance criteria
    Catheter Working LengthWorking length of the catheter as defined in ISO 10555-1 Section 3.6.PASS: Samples met the established acceptance criteria
    Catheter Tip LengthCatheter tip length meets requirements.PASS: Samples met the established acceptance criteria
    System Air LeakageNo air leak into the hub subassembly.PASS: Samples met the established acceptance criteria
    System Liquid LeakageCatheter joint strength meets freedom from leakage (liquid during pressurization) requirements of ISO 10555-1:2013, section 4.7.PASS: Samples met the established acceptance criteria
    Delamination of PTFE LinerPTFE appropriately adhered to the inner lumen of the Catheter with braid reinforcement.PASS: Samples met the established acceptance criteria
    Kink (Distal & Proximal)Catheter remains stable and does not kink during use.PASS: Samples met the established acceptance criteria
    Tip MovementCatheter meets the tip column stiffness requirement.PASS: Samples met the established acceptance criteria
    Tip Linear StiffnessTip flexibility of the Catheter, relative to other devices of similar design, is acceptable.PASS: Samples met the established acceptance criteria
    Coating Lubricity and DurabilityLubriciousness and durability of the Catheter's hydrophilic coating are verified.PASS: Samples met the established acceptance criteria
    Coating LengthCatheter hydrophilic coating length meets design requirements.PASS: Samples met the established acceptance criteria
    Peak Tensile StrengthCatheter joint strength meets the requirements of Section 4.5 of ISO 10555-1.PASS: Samples met the established acceptance criteria
    Introducer IDIntroducer internal diameters meet requirements.PASS: Samples met the established acceptance criteria
    Particulate CountCoating integrity of the Catheter's outer surface meets requirements for content of Particle Matter in alignment with USP<788> counting methods and compared to the reference predicate device.PASS: Samples met the established acceptance criteria
    Burst PressureCatheter can withstand a specified maximum hydrostatic pressure.PASS: Samples met the established acceptance criteria
    Introducer Working LengthWorking length of the introducer is confirmed.PASS: Samples met the established acceptance criteria
    Introducer Separation ForceForce required to separate the introducer is acceptable.PASS: Samples met the established acceptance criteria
    Torque TestNumber of revolutions to failure of the Catheter in simulated anatomy.PASS: Samples exceeded comparator devices in revolutions to failure
    In Vitro Usability StudiesThrombus retrieval patency/durability, (ancillary) device compatibility, and accessory durability demonstrated. Simulated use evaluation of user requirements related to trackability and tip stability during thrombus removal.PASS: Samples met the established acceptance criteria
    Biocompatibility (Chemical Characterization)Determination of extractable species from the test article was performed in purified water, isopropyl alcohol, and hexane.PASS
    Biocompatibility (Cytotoxicity)Evaluation of potential cytotoxic effects using monolayers of L-929 mouse fibroblast cells with 1X MEM extract.PASS
    Biocompatibility (Sensitization)Evaluation of the allergenic potential or sensitizing capacity in guinea pigs.PASS
    Biocompatibility (Irritation)Determination of local irritation in the dermal tissues of rabbits.PASS
    Biocompatibility (Acute Systemic Toxicity)Screening of test article extracts for potential toxic effects from a single-dose systemic injection in mice.PASS
    Biocompatibility (Pyrogenicity)Determination if a saline extract causes a febrile response in rabbits.PASS
    Biocompatibility (ASTM Hemolysis Study)Evaluation of the hemolytic potential of the test articles.PASS
    Biocompatibility (SC5b-9 Complement Activation Assay)Measure of complement activation in Normal Human Serum (NHS).PASS
    Biocompatibility (ASTM Heparinized Platelet and Leukocyte Count)Determination if medical materials exposed to human whole blood would adversely affect platelet and leukocyte ratios.PASS
    Biocompatibility (ASTM Partial Thromboplastin Time (PTT))Screening for detection of coagulation abnormalities in the intrinsic coagulation pathway.PASS
    Biocompatibility (In Vivo Thromboresistance)Evaluation of the thrombogenic potential of a blood contacting medical device in comparison to a predicate device.PASS

    Since the provided document is a 510(k) clearance letter for a physical medical device (catheter and aspiration tubing set) and does not describe any AI/ML components or studies, I cannot answer the questions related to AI/ML specific evaluations:

    1. Sample size used for the test set and the data provenance: Not applicable, as there's no machine learning test set described.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable.
    3. Adjudication method for the test set: Not applicable.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable.
    5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable.
    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): The "ground truth" for the non-clinical tests would be the established engineering and biocompatibility standards and specific design requirements.
    7. The sample size for the training set: Not applicable.
    8. How the ground truth for the training set was established: Not applicable.
    Ask a Question

    Ask a specific question about this device

    K Number
    K223545
    Manufacturer
    Date Cleared
    2023-02-17

    (84 days)

    Product Code
    Regulation Number
    870.1250
    Reference & Predicate Devices
    Predicate For
    Why did this record match?
    Reference Devices :

    K173200

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The APRO 70 Catheter with an aspiration pump and the Alembic Aspiration Tubing is intended for use in the revascularization of patients with acute secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.

    The Alembic Aspiration Tubing is intended to connect the APRO 70 Catheter to the aspiration pump.

    Device Description

    The APRO 70 Catheter is a single-lumen, braid and coil reinforced catheter. The APRO 70 Catheter is designed to remove thrombus from the vasculature using aspiration. The APRO 70 Catheter targets aspiration from the suction pump directly to the thrombus to remove thrombus from an occluded vessel. The APRO 70 Catheter is introduced through a guide catheter or long femoral sheath and into the intracranial vasculature and guided over a neurovascular guidewire under fluoroscopic visualization to the site of the primary occlusion. The distal shaft has a hydrophilic coating to aid navigation through the vasculature. A radiopaque marker is located at the distal end of the catheter for visualization under fluoroscopy. For the aspiration source, the APRO 70 Catheter is used in conjunction with an aspiration pump with pre-specified performance parameters that is connected using the Alembic Aspiration Tubing, along with a legally marketed canister and accessories kit. The APRO 70 Catheter is available in lengths of 125 cm, and 135 cm and is provided with an introducer sheath.

    The Alembic Aspiration Tubing connects the APRO 70 Catheter to the aspiration pump. The flow control valve allows control of the aspiration flow using an ON/OFF switch. It is available in one size.

    AI/ML Overview

    The provided text describes the acceptance criteria and performance data for the APRO 70 Catheter and Alembic Aspiration Tubing. However, it does not contain information about a study proving device performance in the context of AI/ML or human reader performance. The device described is a medical catheter and aspiration tubing, not an AI/ML diagnostic or assistive device. Therefore, questions related to AI/ML specific acceptance criteria, test set characteristics (ground truth, expert adjudication, sample size for test/training sets with medical images), and MRMC studies are not applicable this document.

    Here's the relevant information based on the provided text, focusing on the mechanical and biological aspects of the device, and addressing the applicable parts of your request.

    1. A table of acceptance criteria and the reported device performance

    TestAcceptance CriteriaReported Device Performance (Conclusion)
    Visual and Dimensional CharacteristicsCatheter meets the visual and dimensional specifications.Introducer Sheath meets the visual and dimensional specifications.Aspiration Tubing meets the visual and dimensional specifications.The APRO 70 Catheter met the acceptance criteria.The Introducer Sheath met the acceptance criteria.The Alembic Aspiration Tubing met the acceptance criteria.
    ParticulateCatheter meets the acceptance criteria. Subject device was evaluated with a predicate device under the same test conditions.The APRO 70 Catheter met the acceptance criteria.
    Vacuum IntegrityCatheter with Aspiration Tubing is free from collapse and loss of vacuum between aspiration source and catheter tip.The APRO 70 Catheter and Alembic Aspiration Tubing met the acceptance criteria.
    Kink ResistanceCatheter distal shaft shall not kink.The APRO 70 Catheter met the acceptance criteria.
    Catheter Hub LeakageCatheter does not leak into hub assembly during aspiration, with methods specified in ISO 10555-1, Annex D.The APRO 70 Catheter met the acceptance criteria.
    Catheter Torque StrengthCatheter must withstand the minimum required number of rotations without breakage.The APRO 70 Catheter met the acceptance criteria.
    Dynamic Burst PressureNo damage to catheter with dynamic pressure.The APRO 70 Catheter met the acceptance criteria.
    Fluid LeakageCatheter must withstand pressure with methods specified in ISO 10555-1, Annex C.The APRO 70 Catheter met the acceptance criteria.
    Static Burst (Rupture)Catheter must withstand pressures anticipated for clinical use.The APRO 70 Catheter met the acceptance criteria.
    Tensile Strength of Catheter Hub and ShaftCatheter hub and shaft must meet tensile strength specification.The APRO 70 Catheter met the acceptance criteria.
    Tensile Strength of Catheter TipCatheter tip must meet tip tensile strength specification.The APRO 70 Catheter met the acceptance criteria.
    Tensile Strength of Aspiration TubingAspiration Tubing junction must meet tensile strength specification.The Alembic Aspiration Tubing met the acceptance criteria.
    Simulated UseWhen used per the Instructions for Use with accessory devices in an anatomical neurovascular model, the Catheter and Aspiration Tubing must meet functionality specifications.The APRO 70 Catheter and Alembic Aspiration Tubing met the acceptance criteria.
    UsabilityThe Catheter and Aspiration Tubing were used per the Instructions for Use with accessory devices in an anatomical neurovascular model and compared to a predicate.The APRO 70 Catheter and Alembic Aspiration Tubing met the acceptance criteria.
    Corrosion ResistanceCatheter must be corrosion resistant per ISO 10555-1, Annex A.The APRO 70 Catheter met the acceptance criteria.
    Delivery and Retrieval ForceCatheter delivery and retrieval force must be acceptable. Forces were compared to a predicate.The APRO 70 Catheter met the acceptance criteria.
    Tip Buckling ForceCatheter tip buckling force must be acceptable. Forces were compared to a predicate.The APRO 70 Catheter met the acceptance criteria.
    Sensitization (Guinea Pig)Did not elicit a sensitization response.Non-sensitizing
    Irritation/Intracutaneous ReactivityDemonstrated no evidence of irritation.Non-Irritant
    Cytotoxicity (MEM Elution, L929 cells)Did not elicit a cytotoxic response at 24 hours and 48 hours.Non-cytotoxic
    Hemolysis - IndirectNo significant differences between the test article and the negative control.Non-Hemolytic
    Hemolysis - DirectNo differences between the hemolytic index of the test article and the negative control.Non-Hemolytic
    Partial Thromboplastin Time (PTT)The average clotting time of the test article was greater than vehicle control and negative control.Acceptable clotting times
    SC5b9 Complement ActivationAcceptable - during use, the circulating blood dilutes by over 800X the exposure during the test, providing assurance that the use of the APRO 70 Catheter will not constitute a complement activation safety concern.Acceptable
    ThrombogenicityNo significant thrombus was observed on any of the subject catheters, and the device was determined to not show thrombogenic potential.Non-thrombogenic
    Acute Systemic ToxicityNo weight loss, mortality, or evidence of systemic toxicity from the extract exposure to the mice.Non-toxic
    Material-Mediated PyrogenicityAll individual rabbits for both the test article and negative control showed a total rise in temperature of < 0.5 °C and were determined to be nonpyrogenic.Non-pyrogenic

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    • Bench Testing: The text does not specify sample sizes (number of units tested) for each individual bench test. The source of this data is internal testing by Alembic, LLC.
    • Animal Testing: Conducted on a "porcine model under Good Laboratory Practices (GLP)." The specific number of animals is not provided. This is prospective animal data.
    • Biocompatibility Testing: The text does not specify sample sizes (e.g., number of guinea pigs for sensitization, number of rabbits for pyrogenicity). The provenance of this data is internal testing by Alembic, LLC.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This information is not applicable. The studies described are non-clinical (bench and animal) and do not involve human expert interpretation of medical images or data from a test set to establish ground truth in the context of an AI/ML device.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not applicable as there is no mention of human expert adjudication for a test set in the context of an AI/ML device.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This information is not applicable. No MRMC study was conducted, as this device is a physical medical instrument, not an AI-assisted diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

    This information is not applicable. The device is a physical catheter, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For the non-clinical tests, the "ground truth" is established by direct measurement against predefined specifications, observation of physical properties, and biological responses in animal and in-vitro models according to established laboratory protocols and standards (e.g., ISO, GLP). Examples include:

    • Bench Testing: Direct measurements (dimensions, forces, leak rates), visual inspection for defects, functional assessment in simulated models.
    • Animal Testing: Direct observation (fluoroscopy, compatibility), pathological assessment (histology), and functional evaluation (clot aspiration effectiveness) in a live biological system.
    • Biocompatibility: Standardized biological tests assessing specific endpoints like sensitization, irritation, cytotoxicity, hemolysis, and systemic toxicity.

    8. The sample size for the training set

    This information is not applicable. This is not an AI/ML device, so there is no training set for an algorithm.

    9. How the ground truth for the training set was established

    This information is not applicable. There is no training set for an algorithm.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1